Cost-Utility Evaluation Of Insulin Glargine (300 U/ML) Versus Insulin Glargine (100 U/ML) And Insulin Degludec (100 U/ML) In Patients With Type 2 Diabetes Mellitus In Slovenia
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.466
https://www.valueinhealthjournal.com/article/S1098-3015(17)30800-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
441
First Page :
A481
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30800-8&doi=10.1016/j.jval.2017.08.466